Department of Neurology, Penn State College of Medicine, Hershey, PA, USA.
Department of Neurology, Penn State College of Medicine, Hershey, PA, USA.
J Clin Neurosci. 2019 Nov;69:160-165. doi: 10.1016/j.jocn.2019.08.003. Epub 2019 Aug 27.
Acute ischemic strokes (AIS) with severe neurologic deficits are associated with poor short- and long-term prognosis. Thrombectomy alone or in combination with thrombolysis is used for reperfusion in patients with moderate-to-severe AIS. However, the best therapeutic approach within the setting of telemedicine networks needs to be elucidated further. The objective of this study was to analyze clinical and imaging based outcomes of moderate to severe stroke following treatment with thrombolysis, thrombectomy or a combination of both in a telemedicine network. Data of this retrospective study was abstracted from the institutional telestroke database. Patients with a National Institute of Health Stroke Scale score (NIH-SS ≥ 10) were included into the study. Primary outcome measure was the difference in NIH-SS at admission compared to discharge from the hospital. Secondary outcome measure was the discharge disposition defined as favorable (discharge to home or rehabilitation) versus unfavorable disposition (discharge to hospice/death). Furthermore, outcome was analyzed based on reperfusion status following thrombectomy using the Thrombolysis in Cerebral Infarction (TICI) scale. The NIH-SS improved in all three groups, independent of treatment subtype, with a trend towards best outcomes following thrombolysis and combined treatment therapy compared to thrombectomy alone. In addition, reperfusion rates were higher in the combination group compared to the thrombectomy only group. The number of favorable discharges was similar in all three groups. The present study stresses the benefits of tele-stroke networks in allowing to early identify and treat even patients with severe strokes and benefit from different treatment modalities.
急性缺血性脑卒中(AIS)伴有严重神经功能缺损与短期和长期预后不良相关。单独取栓或与溶栓联合用于治疗中重度 AIS 患者的再灌注。然而,需要进一步阐明远程医疗网络环境下的最佳治疗方法。本研究的目的是分析在远程医疗网络中,溶栓、取栓或两者联合治疗中度至重度脑卒中的临床和影像学结果。本回顾性研究的数据从机构远程脑卒中数据库中提取。纳入的患者 NIH 卒中量表评分(NIH-SS≥10)。主要结局测量指标是入院时与出院时 NIH-SS 的差异。次要结局测量指标是出院时的转归定义为有利(出院回家或康复)与不利转归(出院到临终关怀/死亡)。此外,根据取栓后的再灌注状态,使用血栓切除术治疗脑梗死(TICI)量表分析结果。三组患者 NIH-SS 均有改善,与治疗亚型无关,溶栓联合治疗组的预后好于单独取栓组。此外,联合治疗组的再灌注率高于单独取栓组。三组患者的有利出院率相似。本研究强调了远程脑卒中网络的优势,能够早期识别和治疗即使是重度脑卒中患者,并受益于不同的治疗方式。